Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: A model of gene therapy for Parkinson's disease

Gene Therapy

Volumn 13, Issue 23, 2006, Pages 1639-1644

  Koike, H ^a,b   Ishida, A ^a,b   Shimamura, M ^c   Mizuno, S ^a   Nakamura, T ^a   Ogihara, T ^a   Kaneda, Y ^a   Morishita, R ^a  

^a OSAKA UNIVERSITY   (Japan)

^b AnGes MG Inc   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BETA GALACTOSIDASE; NEUROTROPHIC FACTOR; OXIDOPAMINE; PLASMID DNA; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL LOSS; CELL SURVIVAL; CIRCLING BEHAVIOR; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INJECTION SITE; MALE; NONHUMAN; PARKINSON DISEASE; PLASMID; PRIORITY JOURNAL; RAT; RODENT; STEREOTAXIC SURGERY; STEREOTAXIS; SUBSTANTIA NIGRA; SURVIVAL RATE;

ANIMALS; CELL DEATH; DNA; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GENE THERAPY; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LAC OPERON; MALE; MODELS, ANIMAL; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; TRANSFECTION; TRANSGENES;

RODENTIA;

EID: 33751181265     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302810     Document Type: Article

References (33)

1. Eck SL, Alavi JB, Judy K, Phillips P, Alavi A, Hackney D et al. Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhINF-beta): A phase I trial. Hum Gene Ther 2001; 12: 97-113.
2. Trask TW, Trask RP, Aguilar-Cordova F, Shine HD, Wyde PR, Goodman JC et al. Phase I study of adenoviral delivery of the HSK-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol Ther 2000; 1: 195-203.
3. During MJ, Kaplitt MG, Stern MB, Eidelberg D. Subthalamic GAD gene transfer in Parkinson's disease patients who are candidates for deep brain stimulation. Hum Gene Ther 2001; 12: 1589-1591.
4. Janson C, McPhee S, Bilaniuk L, Haselgrove J, Testaiuti M, Freese A et al. Clinical protocol. Gene Therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. Hum Gene Ther 2002; 13: 1391-1412.
5. Shastry BS. Parkinson's disease: Etiology, pathogenesis and future of gene therapy. Neurosci Res 2001; 41: 5-12.
6. Henningson Jr CT, Stanislaus MA, Gewirtz MA. Embryonic and adult stem cell therapy. J Allergy Clin Immunol 2003; 111 (Suppl. 2): S745-S753.
7. Simpkinsn N, Jankovic J. Neuroprotection in Parkinson disease. Arch Intern Med 2003; 163: 1650-1654.
8. Hurelbrink CB, Barker RA. Prospects for the treatment of Parkinson's disease using neurotrophic factor. Expert Opin Pharmacother 2001; 2: 1531-1543.
9. Wang L, Muramatsu S, Lu Y, Ikeguchi K, Fujimoto K, Okada T et al. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Therapy 2002; 9: 381-399.
10. Bensadoun JC, Deglon N, Tseng JL, Ridet JL, Zurn AD, Aebischer P. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF. Exp Neurol 2000; 164: 15-24.
11. Yasuhara T, Shingo T, Muraoka K, Wen Ji Y, Kameda M, Takeuchi A et al. The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model. Brain Res 2005; 1038: 1-10.
12. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-443.
13. Sun W, Funakoshi H, Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Neurosci 2002; 22: 6537-6548.
14. Miyazawa T, Matsumoto K, Ohmichi H, Yamashima T, Chigasaki H, Nakamura T. Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: A novel neurotrophic factor. J Celebral Blood Flow Metab 1998; 18: 345-348.
15. Date I, Takagi N, Takagi K, Kago T, Matsumoto K, Nakamura T et al. Hepatocyte growth factor improved learning and memory dysfunction of microsphene embolized rats. J Neurosci Res 2004; 78: 442-453.
16. Hamanoue M, Takemoto N, Matsumoto K, Nakamura T, Nakajima K, Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J Neurosci Res 1996; 43: 554-564.
17. Koike H, Morishita R, Iguchi S, Aoki M, Matsumoto K, Nakamura T et al. Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene. FASEB J 2003; 17: 779-781.
18. Tomita N, Morishita R, Taniyama Y, Koike H, Aoki M, Shimizu H et al. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 2003; 107: 1411-1417.
19. Morishita R. Recent progress in gene therapy for cardiovascular disease. Circ J 2002; 66: 1077-1086.
20. Maina F, Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat Neurosci 1999; 2: 213-217.
21. Schnell MA, Zhang Y, Tazelaar J, Gao GP, Yu QC, Qian R et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 2001; 3: 708-722.
22. Dewey RA, Morrissey G, Cowsill CM, Stone D, Bolognani F, Dodd NJ et al. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implication for clinical trial. Nat Med 1999; 5: 1256-1263.
23. Hsich G, Sena-Esteves M, Breakfield XO. Critical issues in gene therapy for neurologic disease. Hum Gene Ther 2002; 13: 579-604.
24. Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M et al. Direct brain of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003; 9: 589-595.
25. Honda S, Kagoshima M, Wanaka A, Tohyama M, Matsumoto K, Nakamura T. Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: Implication as neurotrophic factor. Mol Brain Res 1995; 32: 197-210.
26. Zhang L, Himi T, Morita I, Murota S. Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the phosphatidylinositol-3 kinase/Akt pathway. J Neurosci Res 2000; 59: 489-496.
27. Davey F, Hilton M, Davies AM. Cooperation between HGF and CNTF in promoting the survival and growth of sensory and parasympathetic neurons. Mol Cell Neurosci 2000; 15: 79-87.
28. Hayashi K, Morishita R, Nakagami H, Yoshimura S, Hara A, Matsumoto K et al. Gene therapy for preventing neuronal death using hepatocyte growth factor: In vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons. Gene Therapy 2001; 8: 1167-1173.
29. Baumgartner I, Rauh G, Pieczek A, Wuensch D, Magner M, Kearney M et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med 2000; 132: 880-884.
30. Vale PR, Losordo DW, Milliken CE, Maysky M, Esakof DD, Symes JF et al. Left ventricular electromechanical mapping to assess efficacy of phVEGF165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 2000; 102: 965-974.
31. Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease by therapeutic angiogenesis. Hypertension 2004; 44: 203-209.
32. Schwartz B, Benoist C, Abdallah B, Rangara R, Hassan A, Scherman D et al. Gene transfer by naked DNA into adult mouse brain. Gene Therapy 1996; 3: 405-411.
33. Sekiguchi K, Yasuzumi F, Morishita R. Exogenous expression of hepatocyte growth factor (HGF) in rat striatum by naked fplasmid DNA. Neurosci Res 2003; 45: 173-180.